Form 4: Eli Lilly Director Acquires Shares Through Deferral Plan

Gabrielle Sulzberger, a director at Eli Lilly & Co, acquired shares of common stock through a deferral plan in lieu of cash compensation.

Summary

• Gabrielle Sulzberger, a director at Eli Lilly & Co, acquired 12.73 shares of common stock on December 16, 2024.
• The shares were acquired as part of the Lilly Directors' Deferral Plan, in lieu of cash compensation.
• These shares will be settled in common stock after Ms. Sulzberger's separation from service.
• The transaction was reported on December 17, 2024.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed neutrally to positively by investors.

Positives

• The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.

Future Outlook

The acquired shares will be settled in common stock following the director's separation from service.

Industry Context

This is a routine transaction related to director compensation and is common practice in publicly traded companies.

Comparison to Industry Standards

• Director compensation packages often include stock options or deferred stock units as part of their overall compensation.
• Many companies use deferral plans to align director interests with long-term shareholder value.
• The use of stock units in lieu of cash is a common practice among large publicly traded companies such as Eli Lilly.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns director interests with the company's long-term performance.

Key Dates

Keywords

Eli Lilly, Director, Share Acquisition, Deferral Plan, Stock Units, Common Stock, Lilly Directors' Deferral Plan, Compensation